Advanced glycation end products (AGEs) are proteins or lipids that become glycated after
exposure to sugars. AGEs are prevalent in the diabetic vasculature and contribute to the …

PART I THE ENDOTHELIUM has long been viewed as an inert cellophane-like membrane
that lines the circulatory system with its primary essential function being the maintenance of …

Genome-wide cancer mutation analyses are revealing an extensive landscape of functional
mutations within the noncoding genome, with profound effects on the expression of long …

… However, preliminary studies have shown that stimulation of this receptor by other ligands
which do not themselves generate RO Is (AM.S. and DS, unpublished observation), induces …

S100/calgranulin polypeptides are present at sites of inflammation, likely released by
inflammatory cells targeted to such loci by a range of environmental cues. We report here that …

Advanced glycosylation end products of proteins (AGEs) are nonenzymatically glycosylated
proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes…

AGEs Tumor biology Amphoterin albumin prepared in vitro (7). Its extracellular domain
consists of three immunoglobulin-like regions, one “V”-type followed by two “C”-type (8). RAGE …

Attack by reactive oxygen intermediates, common to many kinds of cell/tissue injury, has
been implicated in the development of diabetic and other vascular diseases. Such oxygen-free …

Amyloid-β peptide (Aβ) interacts with the vasculature to influence Aβ levels in the brain and
cerebral blood flow, providing a means of amplifying the Aβ-induced cellular stress …

The receptor for advanced glycation end products (RAGE), a multi-ligand member of the
immunoglobulin superfamily of cell surface molecules 1 , 2 , interacts with distinct molecules …